{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:53:09Z","timestamp":1762505589322},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2010,5,11]],"date-time":"2010-05-11T00:00:00Z","timestamp":1273536000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Calcif Tissue Int"],"published-print":{"date-parts":[[2010,6]]},"DOI":"10.1007\/s00223-010-9369-9","type":"journal-article","created":{"date-parts":[[2010,5,10]],"date-time":"2010-05-10T00:41:34Z","timestamp":1273452094000},"page":"455-462","source":"Crossref","is-referenced-by-count":13,"title":["The Levels of Somatostatin Receptors in Causative Tumors of Oncogenic Osteomalacia Are Insufficient for Their Agonist to Normalize Serum Phosphate Levels"],"prefix":"10.1007","volume":"86","author":[{"given":"Akira","family":"Ishii","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasuo","family":"Imanishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keisuke","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akimitsu","family":"Miyauchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hajime M.","family":"Koyano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroshi","family":"Kaji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takatoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Koichi","family":"Oba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasato","family":"Komatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masafumi","family":"Kurajoh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuki","family":"Nagata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Goto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Wakasa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshitsugu","family":"Sugimoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takami","family":"Miki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaaki","family":"Inaba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiki","family":"Nishizawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2010,5,11]]},"reference":[{"key":"9369_CR1","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1056\/NEJMoa020881","volume":"348","author":"KB Jonsson","year":"2003","unstructured":"Jonsson KB, Zahradnik R, Larsson T, White KE, Sugimoto T, Imanishi Y, Yamamoto T, Hampson G, Koshiyama H, Ljunggren O, Oba K, Yang IM, Miyauchi A, Econs MJ, Lavigne J, Juppner H (2003) Fibroblast growth factor 23 in oncogenic osteomalacia and X-linked hypophosphatemia. N Engl J Med 348:1656\u20131663","journal-title":"N Engl J Med"},{"key":"9369_CR2","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jcem.86.2.7408","volume":"86","author":"KE White","year":"2001","unstructured":"White KE, Jonsson KB, Carn G, Hampson G, Spector TD, Mannstadt M, Lorenz-Depiereux B, Miyauchi A, Yang IM, Ljunggren O, Meitinger T, Strom TM, Juppner H, Econs MJ (2001) The autosomal dominant hypophosphatemic rickets (ADHR) gene is a secreted polypeptide overexpressed by tumors that cause phosphate wasting. J Clin Endocrinol Metab 86:497\u2013500","journal-title":"J Clin Endocrinol Metab"},{"key":"9369_CR3","doi-asserted-by":"crossref","first-page":"4957","DOI":"10.1210\/jc.2002-021105","volume":"87","author":"Y Yamazaki","year":"2002","unstructured":"Yamazaki Y, Okazaki R, Shibata M, Hasegawa Y, Satoh K, Tajima T, Takeuchi Y, Fujita T, Nakahara K, Yamashita T, Fukumoto S (2002) Increased circulatory level of biologically active full-length FGF-23 in patients with hypophosphatemic rickets\/osteomalacia. J Clin Endocrinol Metab 87:4957\u20134960","journal-title":"J Clin Endocrinol Metab"},{"key":"9369_CR4","first-page":"4003","volume":"117","author":"IZ Ben-Dov","year":"2007","unstructured":"Ben-Dov IZ, Galitzer H, Lavi-Moshayoff V, Goetz R, Kuro OM, Mohammadi M, Sirkis R, Naveh-Many T, Silver J (2007) The parathyroid is a target organ for FGF23 in rats. J Clin Invest 117:4003\u20134008","journal-title":"J Clin Invest"},{"key":"9369_CR5","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1517\/17460440903022743","volume":"4","author":"Y Imanishi","year":"2009","unstructured":"Imanishi Y, Inaba M, Kawata T, Nishizawa Y (2009) Animal models of hyperfunctioning parathyroid diseases for drug development. Expert Opin Drug Discov 4:727\u2013740","journal-title":"Expert Opin Drug Discov"},{"key":"9369_CR6","first-page":"554","volume":"14","author":"A Prader","year":"1959","unstructured":"Prader A, Illig R, Uehlinger E, Stalder G (1959) Rachitis infolge Knochentumors. Helv Paediatr Acta 14:554\u2013565","journal-title":"Helv Paediatr Acta"},{"key":"9369_CR7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-200401000-00001","volume":"28","author":"AL Folpe","year":"2004","unstructured":"Folpe AL, Fanburg-Smith JC, Billings SD, Bisceglia M, Bertoni F, Cho JY, Econs MJ, Inwards CY, Jan de Beur SM, Mentzel T, Montgomery E, Michal M, Miettinen M, Mills SE, Reith JD, O\u2019Connell JX, Rosenberg AE, Rubin BP, Sweet DE, Vinh TN, Wold LE, Wehrli BM, White KE, Zaino RJ, Weiss SW (2004) Most osteomalacia-associated mesenchymal tumors are a single histopathologic entity: an analysis of 32 cases and a comprehensive review of the literature. Am J Surg Pathol 28:1\u201330","journal-title":"Am J Surg Pathol"},{"key":"9369_CR8","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1097\/00003072-199902000-00016","volume":"24","author":"BD Nguyen","year":"1999","unstructured":"Nguyen BD, Wang EA (1999) Indium-111 pentetreotide scintigraphy of mesenchymal tumor with oncogenic osteomalacia. Clin Nucl Med 24:130\u2013131","journal-title":"Clin Nucl Med"},{"key":"9369_CR9","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1056\/NEJMoa010839","volume":"345","author":"J Seufert","year":"2001","unstructured":"Seufert J, Ebert K, Muller J, Eulert J, Hendrich C, Werner E, Schuuze N, Schulz G, Kenn W, Richtmann H, Palitzsch KD, Jakob F (2001) Octreotide therapy for tumor-induced osteomalacia. N Engl J Med 345:1883\u20131888","journal-title":"N Engl J Med"},{"key":"9369_CR10","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1046\/j.1365-2265.2001.01056.x","volume":"54","author":"Y Rhee","year":"2001","unstructured":"Rhee Y, Lee JD, Shin KH, Lee HC, Huh KB, Lim SK (2001) Oncogenic osteomalacia associated with mesenchymal tumour detected by indium-111 octreotide scintigraphy. Clin Endocrinol (Oxf) 54:551\u2013554","journal-title":"Clin Endocrinol (Oxf)"},{"key":"9369_CR11","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1359\/jbmr.2002.17.6.1102","volume":"17","author":"SM Beur De","year":"2002","unstructured":"De Beur SM, Finnegan RB, Vassiliadis J, Cook B, Barberio D, Estes S, Manavalan P, Petroziello J, Madden SL, Cho JY, Kumar R, Levine MA, Schiavi SC (2002) Tumors associated with oncogenic osteomalacia express genes important in bone and mineral metabolism. J Bone Miner Res 17:1102\u20131110","journal-title":"J Bone Miner Res"},{"key":"9369_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s00264-001-0318-0","volume":"26","author":"M Moran","year":"2002","unstructured":"Moran M, Paul A (2002) Octreotide scanning in the detection of a mesenchymal tumour in the pubic symphysis causing hypophosphataemic osteomalacia. Int Orthop 26:61\u201362","journal-title":"Int Orthop"},{"key":"9369_CR13","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/00003072-200208000-00007","volume":"27","author":"CA Garcia","year":"2002","unstructured":"Garcia CA, Spencer RP (2002) Bone and In-111 octreotide imaging in oncogenic osteomalacia: a case report. Clin Nucl Med 27:582\u2013583","journal-title":"Clin Nucl Med"},{"key":"9369_CR14","doi-asserted-by":"crossref","first-page":"3626","DOI":"10.1200\/JCO.2005.05.043","volume":"23","author":"P Auethavekiat","year":"2005","unstructured":"Auethavekiat P, Roberts JR, Biega TJ, Toney MO, Christensen RS, Belnap CM, Berenberg JL (2005) Case 3. Oncogenic osteomalacia associated with hemangiopericytoma localized by octreotide scan. J Clin Oncol 23:3626\u20133628","journal-title":"J Clin Oncol"},{"key":"9369_CR15","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/01.rlu.0000238192.37389.28","volume":"31","author":"BD Nguyen","year":"2006","unstructured":"Nguyen BD (2006) Coexisting hyperparathyroidism and oncogenic osteomalacia: sestamibi and somatostatin receptor scintigraphy. Clin Nucl Med 31:648\u2013651","journal-title":"Clin Nucl Med"},{"key":"9369_CR16","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/RLU.0b013e3180a1ad1d","volume":"32","author":"A Robertson","year":"2007","unstructured":"Robertson A, Mansberg R, Mansberg V, Van der Wall H, Hooper M (2007) Tumor-induced osteomalacia: a case of diagnostic dilemma. Clin Nucl Med 32:631\u2013634","journal-title":"Clin Nucl Med"},{"key":"9369_CR17","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.bone.2006.07.027","volume":"40","author":"MS Elston","year":"2007","unstructured":"Elston MS, Stewart IJ, Clifton-Bligh R, Conaglen JV (2007) A case of oncogenic osteomalacia with preoperative secondary hyperparathyroidism: description of the biochemical response of FGF23 to octreotide therapy and surgery. Bone 40:236\u2013241","journal-title":"Bone"},{"key":"9369_CR18","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1097\/RLU.0b013e31818866bf","volume":"33","author":"M Duet","year":"2008","unstructured":"Duet M, Kerkeni S, Sfar R, Bazille C, Liote F, Orcel P (2008) Clinical impact of somatostatin receptor scintigraphy in the management of tumor-induced osteomalacia. Clin Nucl Med 33:752\u2013756","journal-title":"Clin Nucl Med"},{"key":"9369_CR19","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.crad.2007.05.017","volume":"63","author":"S Harish","year":"2008","unstructured":"Harish S, Jurriaans E, Jan E, Sur M, Colterjohn N (2008) Giant cell tumour of soft tissue causing oncogenic osteomalacia: report demonstrating the use of octreotide scintigraphy in tumour localization. Clin Radiol 63:101\u2013107","journal-title":"Clin Radiol"},{"key":"9369_CR20","first-page":"1922","volume":"56","author":"JC Reubi","year":"1996","unstructured":"Reubi JC, Waser B, Laissue JA, Gebbers JO (1996) Somatostatin and vasoactive intestinal peptide receptors in human mesenchymal tumors: in vitro identification. Cancer Res 56:1922\u20131931","journal-title":"Cancer Res"},{"key":"9369_CR21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0140-6736(02)07846-7","volume":"359","author":"SM Jan de Beur","year":"2002","unstructured":"Jan de Beur SM, Streeten EA, Civelek AC, McCarthy EF, Uribe L, Marx SJ, Onobrakpeya O, Raisz LG, Watts NB, Sharon M, Levine MA (2002) Localisation of mesenchymal tumours by somatostatin receptor imaging. Lancet 359:761\u2013763","journal-title":"Lancet"},{"key":"9369_CR22","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.2169\/internalmedicine.45.1797","volume":"45","author":"K Yoshioka","year":"2006","unstructured":"Yoshioka K, Nagata R, Ueda M, Yamaguchi T, Konishi Y, Hosoi M, Inoue T, Yamanaka K, Iwai Y, Sato T (2006) Phosphaturic mesenchymal tumor with symptoms related to osteomalacia that appeared one year after tumorectomy. Intern Med 45:1157\u20131160","journal-title":"Intern Med"},{"key":"9369_CR23","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1530\/EJE-07-0779","volume":"158","author":"G Boekel van","year":"2008","unstructured":"van Boekel G, Ruinemans-Koerts J, Joosten F, Dijkhuizen P, van Sorge A, de Boer H (2008) Tumor producing fibroblast growth factor 23 localized by two-staged venous sampling. Eur J Endocrinol 158:431\u2013437","journal-title":"Eur J Endocrinol"},{"key":"9369_CR24","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1016\/j.lfs.2005.09.052","volume":"78","author":"K Kobayashi","year":"2006","unstructured":"Kobayashi K, Imanishi Y, Koshiyama H, Miyauchi A, Wakasa K, Kawata T, Goto H, Ohashi H, Koyano HM, Mochizuki R, Miki T, Inaba M, Nishizawa Y (2006) Expression of FGF23 is correlated with serum phosphate level in isolated fibrous dysplasia. Life Sci 78:2295\u20132301","journal-title":"Life Sci"},{"key":"9369_CR25","doi-asserted-by":"crossref","first-page":"289","DOI":"10.3346\/jkms.1994.9.4.289","volume":"9","author":"YK Park","year":"1994","unstructured":"Park YK, Unni KK, Beabout JW, Hodgson SF (1994) Oncogenic osteomalacia: a clinicopathologic study of 17 bone lesions. J Korean Med Sci 9:289\u2013298","journal-title":"J Korean Med Sci"},{"key":"9369_CR26","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S8756-3282(00)00334-3","volume":"27","author":"R Kumar","year":"2000","unstructured":"Kumar R (2000) Tumor-induced osteomalacia and the regulation of phosphate homeostasis. Bone 27:333\u2013338","journal-title":"Bone"},{"key":"9369_CR27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00198-007-0554-2","volume":"19","author":"M Kurajoh","year":"2008","unstructured":"Kurajoh M, Inaba M, Yamada S, Imanishi Y, Tsuchida T, Ishimura E, Nishizawa Y (2008) Association of increased active PTH(1\u201384) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D. Osteoporos Int 19:709\u2013716","journal-title":"Osteoporos Int"},{"key":"9369_CR28","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1373\/clinchem.2003.026831","volume":"50","author":"M Inaba","year":"2004","unstructured":"Inaba M, Nakatsuka K, Imanishi Y, Watanabe M, Mamiya Y, Ishimura E, Nishizawa Y (2004) Technical and clinical characterization of the Bio-PTH (1\u201384) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone. Clin Chem 50:385\u2013390","journal-title":"Clin Chem"},{"key":"9369_CR29","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1507\/endocrj.52.605","volume":"52","author":"Y Taniyama","year":"2005","unstructured":"Taniyama Y, Suzuki T, Mikami Y, Moriya T, Satomi S, Sasano H (2005) Systemic distribution of somatostatin receptor subtypes in human: an immunohistochemical study. Endocr J 52:605\u2013611","journal-title":"Endocr J"},{"key":"9369_CR30","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1006\/bbrc.1993.1412","volume":"192","author":"YC Patel","year":"1993","unstructured":"Patel YC, Greenwood M, Kent G, Panetta R, Srikant CB (1993) Multiple gene transcripts of the somatostatin receptor SSTR2: tissue selective distribution and cAMP regulation. Biochem Biophys Res Commun 192:288\u2013294","journal-title":"Biochem Biophys Res Commun"},{"key":"9369_CR31","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1053\/j.ajkd.2008.12.034","volume":"53","author":"S Matsuo","year":"2009","unstructured":"Matsuo S, Imai E, Horio M, Yasuda Y, Tomita K, Nitta K, Yamagata K, Tomino Y, Yokoyama H, Hishida A (2009) Revised equations for estimated GFR from serum creatinine in Japan. Am J Kidney Dis 53:982\u2013992","journal-title":"Am J Kidney Dis"},{"key":"9369_CR32","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1056\/NEJM199601253340408","volume":"334","author":"SW Lamberts","year":"1996","unstructured":"Lamberts SW, van der Lely AJ, de Herder WW, Hofland LJ (1996) Octreotide. N Engl J Med 334:246\u2013254","journal-title":"N Engl J Med"},{"key":"9369_CR33","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.4158\/EP.14.9.1108","volume":"14","author":"MA Habra","year":"2008","unstructured":"Habra MA, Jimenez C, Huang SC, Cote GJ, Murphy WA Jr, Gagel RF, Hoff AO (2008) Expression analysis of fibroblast growth factor-23, matrix extracellular phosphoglycoprotein, secreted frizzled-related protein-4, and fibroblast growth factor-7: identification of fibroblast growth factor-23 and matrix extracellular phosphoglycoprotein as major factors involved in tumor-induced osteomalacia. Endocr Pract 14:1108\u20131114","journal-title":"Endocr Pract"}],"container-title":["Calcified Tissue International"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-010-9369-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00223-010-9369-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00223-010-9369-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,24]],"date-time":"2019-05-24T07:37:58Z","timestamp":1558683478000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00223-010-9369-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2010,5,11]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2010,6]]}},"alternative-id":["9369"],"URL":"https:\/\/doi.org\/10.1007\/s00223-010-9369-9","relation":{},"ISSN":["0171-967X","1432-0827"],"issn-type":[{"value":"0171-967X","type":"print"},{"value":"1432-0827","type":"electronic"}],"subject":[],"published":{"date-parts":[[2010,5,11]]}}}